March 24, 2022 March 24, 2022Categories EditorialsCome again? Communicating clearly about risk of recurrence after early-stage breast cancerMary Lou Smith and colleagues at the Research Advocacy Network recently explored how well patients with early-stage breast cancer understand risk of their cancer coming back
September 20, 2021 September 20, 2021Categories EditorialsThe language of (lung) cancerA new language guide encourages respect, eliminates blame, and promotes health equity
June 24, 2021 June 24, 2021Categories EditorialsAdvocacy and the NCI’s National Clinical Trials NetworkAdvocates play an important role in each of the NCTN groups, helping to inform the design and implementation of clinical trials
June 24, 2021 June 24, 2021Categories EditorialsOngoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment optionEach arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.